Vasomotor Symptoms
📧 Sign up to get email alerts when something new happens for Vasomotor Symptoms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the pharmacokinetics and safety of BAY3427080 (NT-814) in postmenopausal women with vasomotor symptoms; …
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms [Phase 2]
Phase 2 study evaluating RAD1901 for vasomotor symptoms in postmenopausal women was terminated; results were posted but no further developme…
-
CLINICAL_TRIALS trial_result · 2019-01-14Clinical Trial Update: Study of Erenumab (AMG 334) in Women With Hot Flashes [Phase 1]
Phase 1 clinical trial of erenumab (AMG 334) in women with vasomotor symptoms and hot flashes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients
A postmarketing surveillance study of desvenlafaxine succinate (Pristiq) in Filipino patients with major depressive disorder and vasomotor s…
-
CLINICAL_TRIALS research · 2015-10-22Clinical Trial Update: MsFLASH-04: Pilot Trial: Telephone Behavioral Therapy for Menopause-related Sleep Disturbance [NA]
A completed pilot trial (MsFLASH-04) evaluating telephone-delivered behavioral therapy for menopause-related sleep disturbance.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-07-23FDA Approved: DUAVEE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Duavee (conjugated estrogens/bazedoxifene) to update the labeling, potentially expanding its app…
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms. [Phase 3]
A Phase 3 safety and efficacy trial evaluating a drospirenone/estradiol combination for vasomotor symptoms in postmenopausal Chinese women h…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation [NA]
Completion update for the MsFLASH-02 trial, a 3-by-2 factorial study evaluating yoga, physical exercise, and omega-3 supplementation for rel…
-
CLINICAL_TRIALS trial_result · 2014-07-30Clinical Trial Update: Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013) [Phase 3]
Phase 3 dose-finding trial assessing safety and efficacy of Org 50081 (Esmirtazapine) for vasomotor symptoms in postmenopausal menopause; st…
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012) [Phase 3]
Phase 3 dose-finding trial of Org50081 (Esmirtazapine) for vasomotor symptoms in menopause completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS) [Phase 3]
Phase 3 trial results for Brisdelle (paroxetine mesylate) evaluating efficacy and safety for vasomotor symptoms in postmenopausal women have…
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause [Phase 2]
Phase 2 study evaluating eight-week efficacy and safety of Brisdelle (paroxetine mesylate) for vasomotor symptoms in menopause; results have…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women [Phase 3]
Phase 3 trial evaluating gabapentin extended-release for vasomotor symptoms (hot flashes) in postmenopausal women has completed and posted r…
-
CLINICAL_TRIALS trial_result · 2011-09-28Clinical Trial Update: Clinical Trial to Evaluate the Efficacy of FITOGYN Versus Placebo on the Vasomotor Symptomatology Associated With Menopause [Phase 4]
Phase 4 clinical trial evaluating the efficacy of FITOGYN versus placebo for vasomotor symptoms in postmenopausal women with moderate sympto…
-
CLINICAL_TRIALS trial_result · 2011-08-17Clinical Trial Update: Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women [Phase 3]
Pfizer completed a Phase 3 trial evaluating desvenlafaxine succinate for vasomotor symptoms in menopausal women, with results posted in 2011…
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: Mindfulness-Based Stress Reduction for Hot Flashes [EARLY_Phase 1]
An EARLY_PHASE1 trial evaluated mindfulness-based stress reduction for vasomotor symptoms (hot flashes) associated with menopause and has co…
-
CLINICAL_TRIALS research · 2008-10-24Clinical Trial Update: Development of Active Safety Surveillance System for Traditional Chinese Medicine
The document reports on the completion of a clinical trial focused on developing an active safety surveillance system for traditional Chines…
-
CLINICAL_TRIALS trial_result · 2007-12-28Clinical Trial Update: Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of DVS SR in healthy Japanese women has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-20Clinical Trial Update: Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women. [Phase 4]
Phase 4 trial evaluating the estradiol/trimegestone combination for vasomotor symptoms in postmenopausal women has completed. Sponsor Wyeth …
-
CLINICAL_TRIALS trial_result · 2007-01-11Clinical Trial Update: Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause [Phase 3]
This Phase 3 trial evaluated the safety and efficacy of DVS-223 SR for vasomotor symptoms associated with menopause. The study was sponsored…